Researchers launch study on Ebola treatments as Congo outbreak worsens
The randomized study will test remdesivir and MBP134 in up to 1,000 patients as WHO officials seek better survival rates.
- Researchers launched a study on two potential Ebola treatments to combat the ongoing outbreak in eastern Congo, with the World Health Organization enrolling the first participant.
- The current outbreak is caused by the Bundibugyo virus, which is less common and lacks specific treatments or vaccines.
- More than 1,400 people have been diagnosed with the virus and 438 have died, according to WHO Director-General Tedros Adhanom Ghebreyesus.
- The trial is conducted at one Ebola treatment center in Ituri province, aiming to test if two drugs can improve survival.
21 Articles
21 Articles
This study is coordinated by the National Biomedical Research Institute of the Democratic Republic of the Congo, with the support of a coalition of partners, including WHO.
The World Health Organization has announced that a trial of two potential treatments for the Bundibugyo variant of the Ebola virus has begun in the Democratic Republic of Congo.
ledauphine.com
lalsace.frA clinical trial of two Ebola treatments began this Thursday in the Democratic Republic of the Congo. Hope for the whole country, ravaged by the epidemic.
WHO tests new medicine targeting Ebola
WHO tests new medicine targeting Ebola Siya Tsewu Thu, 07/02/2026 - 22:00 JOHANNESBURG - The World Health Organization says a first patient has been enrolled in a clinical trial testing two potential treatments for the Ebola outbreak in the Democratic Republic of the Congo.The trial is expected to assess whether the new medicines are safe and effective to treat the growing outbreak.Tedros Adhanom Ghebreyesus, World Health Organizat…
Coverage Details
Bias Distribution
- 54% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
